Current Opinion in Rheumatology

Papers
(The TQCC of Current Opinion in Rheumatology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial introduction281
Giant cell arteritis: update on pathogenesis and clinical implications70
Current approach to muscle imaging in myositis69
Urticarial vasculitis60
Epidemiology and outcomes of rheumatoid arthritis60
Update on antineutrophil cytoplasmic autoantibody vasculitis in children58
Selective immunoglobulin E deficiency: an overlooked hypogammaglobulinemia and its association with rheumatoid arthritis54
What's next in psoriatic arthritis therapy? A look at the pipeline44
Current views on lupus in children41
Polymyalgia rheumatica and giant cell arteritis: diagnosis and management38
Editorial introductions37
Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice36
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burden32
Axial spondyloarthritis guidelines – aiming for maximum impact29
Comorbidities in idiopathic inflammatory myopathies: population-based evidence on risk subgroups and implications for delivery of care27
Rheumatoid arthritis – the challenge of heterogeneity26
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials24
A comprehensive review of systemic sclerosis–primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype23
The gut microbiota in spondyloarthritis: an update23
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus23
Editorial introductions22
Updates on translational and clinical research in systemic sclerosis22
Editorial introductions22
Rheumatoid arthritis contributes to comorbidity burden through systemic inflammation and autoimmunity: examples of atherosclerotic cardiovascular disease, interstitial lung disease, and depression21
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation21
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis21
Pathogenesis of skin damage in lupus: recent advances and future directions18
Management of cutaneous manifestations of systemic sclerosis: current approaches and emerging therapies18
Insights into the pathogenic role of neutrophils in systemic lupus erythematosus18
Editorial introduction18
Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research18
Editorial introductions18
Epidemiology of myositis17
The role of neutrophil extracellular traps in inflammatory rheumatic diseases17
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis16
Diagnosis and management of primary heart involvement in systemic sclerosis14
How common is vasculitis: what do population-based data tell us?14
Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists14
New developments related to lung complications in pediatric rheumatic disease14
Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.014
Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets14
Editorial introductions14
Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?14
AI am the future: artificial intelligence in pediatric rheumatology13
Biomarker discovery in psoriatic disease13
Vasculitis and the NLRP3 inflammasome13
Environmental and occupational contributors to autoimmune, inflammatory, and musculoskeletal rheumatic disease: a review of emerging evidence and clinical implications13
Investigating gout flares: beyond a definition13
Management of postinfectious inflammatory arthritis12
Editorial introduction12
Heart involvement in systemic sclerosis: emerging concepts12
Epidemiology of osteoarthritis: literature update 2022–202312
Advances in the diagnosis and treatment of Sjögren disease12
Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI11
Emerging biologic therapies for systemic lupus erythematosus11
Update on streptococcal-associated rheumatic disease11
Exploring challenges in the management and treatment of inclusion body myositis11
Animal models in systemic sclerosis: an update11
Eosinophilic granulomatosis with polyangiitis: recent therapeutic advances11
Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications10
Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment10
Current management of giant cell arteritis and its complications10
The contribution of endothelial cells to tissue fibrosis10
What have we learned about systemic sclerosis from the EUSTAR database?9
Revisiting the CD40-CD40L axis: from mechanistic insight to therapeutic renewal in autoimmune disease9
New therapies in anti-MDA5 antibody-positive dermatomyositis9
Calcinosis in systemic sclerosis9
Editorial introduction9
Recent developments in the synovial fibroblast pathobiology field in rheumatoid arthritis9
Biomarkers in juvenile idiopathic arthritis: towards precision diagnosis and personalized therapy?9
Pregnancies in women with antineutrophil cytoplasmatic antibody associated vasculitis9
Gastrointestinal disease in systemic sclerosis: the neglected organ system?9
0.074206113815308